Evaluation of efficacy and safety of PARP inhibitors in breast cancer: A systematic review and meta-analysis

BACKGROUND: Many breast cancer clinical trials with PARPi have been completed or are currently carried out, either by monotherapy or combined with chemotherapy. We aim to assess the efficacy and safety of PARPi in breast cancer patients as compared to chemotherapy. METHODS: A comprehensive literatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xiao-Fei, Ren, Xiao-Lu, Yang, Jie-Quan, Shi, Jian-Jun, Bai, Jun-Heng, Cui, Meng-Sheng, Dong, Wen-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215282/
https://www.ncbi.nlm.nih.gov/pubmed/34130011
http://dx.doi.org/10.1016/j.breast.2021.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215282/
https://www.ncbi.nlm.nih.gov/pubmed/34130011
http://dx.doi.org/10.1016/j.breast.2021.05.009

Ejemplares similares